# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-008136
Filing Date
2025-03-18
Accepted
2025-03-18 07:10:34
Documents
85
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | eton20241231_10k.htm iXBRL | 10-K | 1641744
2 | EXHIBIT 10.11 | ex_788745.htm | EX-10.11 | 483837
3 | EXHIBIT 10.14 | ex_791375.htm | EX-10.14 | 150102
4 | EXHIBIT 31.1 | ex_726706.htm | EX-31.1 | 9716
5 | EXHIBIT 31.2 | ex_726707.htm | EX-31.2 | 9381
6 | EXHIBIT 32.1 | ex_726708.htm | EX-32.1 | 6579
7 | EXHIBIT 97 - POLICY RELATING TO RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION | ex_726709.htm | EX-97 | 26465
| Complete submission text file | 0001437749-25-008136.txt |  | 9308357

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | eton-20241231.xsd | EX-101.SCH | 74275
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | eton-20241231_cal.xml | EX-101.CAL | 48178
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | eton-20241231_def.xml | EX-101.DEF | 590168
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | eton-20241231_lab.xml | EX-101.LAB | 503407
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | eton-20241231_pre.xml | EX-101.PRE | 625048
88 | EXTRACTED XBRL INSTANCE DOCUMENT | eton20241231_10k_htm.xml | XML | 1114988

Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38738 | Film No.: 25746482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)